Media

Washington, D.C. – U.S. Representative Lloyd Doggett (D-TX), Chairman of the House Ways and Means Health Subcommittee, issued the following statement in reaction to Dr. Rick Bright’s whistleblower complaint:

Washington, D.C. – As many college students and their families are facing financial difficulties that may impact their ability to return to class this fall, U.S. Representative Lloyd Doggett (D-TX), Chairman of the House Ways and Means Health Subcommittee, is introducing the American Opportunity Student Tax Relief Act, joined by U.S. Representative Brian Fitzpatrick (R-PA). This legislation assures that college emergency grants to students authorized by the CARES Act are not taxed. It expands the American Opportunity Tax Credit (AOTC)—which already helps millions of students pay for the costs of college—with both a short-term expansion of the incentive during the pandemic and long-term improvements to the program.

Washington, D.C. – Today, U.S. Representative Lloyd Doggett (D-TX), Chairman of the House Ways and Means Health Subcommittee, led Members in urging Gilead CEO Daniel O’Day to detail the company’s plans for remdesivir, including securing and scaling up the supply chain, complete disclosures of taxpayer investment in the development of the drug, and purchase and pricing arrangements. As remdesivir—which has been developed with significant taxpayer investment—receives FDA emergency use authorization, the lawmakers questioned its affordability and accessibility for patients.

Washington, D.C. – As the COVID-19 pandemic places unique pressures on food supply chains in the United States, U.S. Representative Lloyd Doggett (D-TX), Chairman of the House Ways and Means Health Subcommittee, led Members in urging the Department of Agriculture to curb the extreme measures for “depopulation” at some animal slaughter facilities. Their letter raises concerns about mass suffocation of animals who are being quickly cleared from facilities and urges use of more humane practices.

Washington, D.C. – Following today’s Food and Drug Administration (FDA) announcement of changes in requirements for antibody tests, U.S. Representative Lloyd Doggett (D-TX), Chairman of the House Ways and Means Health Subcommittee, released the following statement: